The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling after short-term preoperative endocrine therapy to identify oestrogen receptor positive (ER+)/HER2+ early breast tumours with favourable prognosis.
 
Milana Bergamino Sirvén
Consulting or Advisory Role - AstraZeneca; Pfizer
Speakers' Bureau - AstraZeneca; Eisai; Novartis; Novartis
Patents, Royalties, Other Intellectual Property - Patent filled with the Institute of Cancer Research on the discrovery of new molecular subgroups in ER+/HER2+ Breast Cancer
 
Elena Lopez-Knowles
Patents, Royalties, Other Intellectual Property - Patent filled for the new molecular subgroups with the ICR in early ER+/HER2+ BC
 
Xixuan Zhu
No Relationships to Disclose
 
Holly Tovey
Honoraria - Bayer
Research Funding - Cancer Research UK
 
Hui Xiao
No Relationships to Disclose
 
Lucy Kilburn
Research Funding - Cancer Research UK
 
Anastasia Alataki
No Relationships to Disclose
 
Chris Holcombe
No Relationships to Disclose
 
Anthony Skene
No Relationships to Disclose
 
Ian E. Smith
No Relationships to Disclose
 
John Forsyth Russell Robertson
No Relationships to Disclose
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Eugene F. Schuster
No Relationships to Disclose
 
Mitchell Dowsett
Honoraria - Cancer Research UK
Consulting or Advisory Role - AstraZeneca; GTx; Lilly; Orion; Radius Health
Research Funding - Pfizer (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Myriad Genetic Laboratories; Pfizer
 
Maggie Chon U Cheang
Consulting or Advisory Role - Veracyte
Patents, Royalties, Other Intellectual Property - M.C.U.C. has a patent for Breast Cancer Classifier: US Patent No. 9,631,239 with royalties paid.
Other Relationship - NanoString Technologies